Biomarker Conference for Bay Area Diagnostics & Tools Companies

A short flight south to a full biomarker program

ImmunoMark Summit’s West Coast edition runs in San Diego on 10–11 February 2027. For a diagnostics, genomics or tools company based in South San Francisco, the Peninsula, the East Bay or Silicon Valley, it is a biomarker conference you can staff from home: a 90-minute flight, a two-day Stream 2 program on Biomarkers & Companion Diagnostics, and pre-scheduled 1:1 meetings with the delegates you choose.

The launch edition expects 300+ senior delegates from pharma, biotech, diagnostics and academia. It uses the format proven in London: two parallel streams, keynotes, panels and case studies, a drinks reception at the end of Day 1, and 20-minute 1:1 meetings picked from the full delegate list and profiles, which arrive about 10 days before the event.

The segments Bay Area companies sell into biomarker teams

The Bay Area combines therapeutics R&D with a dense base of tools, sequencing and diagnostics companies. The City of South San Francisco calls itself the birthplace of biotechnology, dating back to Genentech’s founding there in 1976, and counts over 250 biotech companies within its limits.

A few public examples show the range of segments in the region. They are examples of the cluster only, not ImmunoMark sponsors or delegates.

If your company sits in any of these segments, the buyers you want are translational, biomarker and precision medicine teams at pharma and biotech. On the San Diego biomarker faculty, those functions include Hyun Yong Jin, Senior Principal Scientist at Genentech, and Abhishek Aggarwal, Director, Pathobiology at Gilead Sciences, both Bay Area-headquartered companies.

Where February fits in a Bay Area event and budget plan

The Bay Area’s own event year opens with J.P. Morgan Healthcare Conference week in San Francisco in January. San Diego follows about four weeks later, which gives your team time to turn January partnering conversations into follow-up meetings with biomarker and translational teams.

Budget timing depends on your fiscal year. For a company on a calendar fiscal year, such as 10x Genomics, a February sponsorship falls in Q1, so it needs to be in the plan approved at the end of 2026. Agilent’s fiscal year ends on 31 October, so for companies on a similar cycle February falls in Q2, and the spend comes from a budget already set in the fall. Either way, deciding in November or December gives you time to pick sessions, brief speakers and choose meeting targets once the delegate list arrives.

For the rest of the regional calendar, see our guide to Bay Area biotech conferences.